Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion-Reference-Cited by-同舟云学术

Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion

Published:2009-10 Issue:43 Volume:27 Page:5956-5963
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Baldwin Susan L.,Shaverdian Narek,Goto Yasuyuki,Duthie Malcolm S.,Raman Vanitha S.,Evers Tara,Mompoint Farah,Vedvick Thomas S.,Bertholet Sylvie,Coler Rhea N.,Reed Steven G.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference32 articles.

1. New vaccine approaches for seasonal and pandemic influenza;Palache;Vaccine,2008

2. Antibody response to influenza vaccination in the elderly: a quantitative review;Goodwin;Vaccine,2006

3. T cell responses are better correlates of vaccine protection in the elderly;McElhaney;J Immunol,2006

4. Immune response to influenza vaccination in a large healthy elderly population;Bernstein;Vaccine,1999

5. A virus-specific cytotoxic T lymphocyte activity declines with advancing age;Powers;J Am Geriatr Soc,1993

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination with ancestral SARS-CoV-2 spike adjuvanted with TLR agonists provides cross-protection against XBB.1;npj Viruses;2024-08-06

2. Design and Evaluation of Chimeric Plasmodium falciparum Circumsporozoite Protein-Based Malaria Vaccines;Vaccines;2024-03-25

3. Cobra Hemagglutinin and cGAMP Loaded Ace‐Dex Microparticles Provide a Broadly Active and Shelf‐Stable Influenza Vaccine Platform;Advanced Therapeutics;2023-12-20

4. Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial;Infectious Diseases and Therapy;2023-05-11

5. Towards the development of subunit vaccines against tuberculosis: The key role of adjuvant;Tuberculosis;2023-03